Patents by Inventor Whitney W. Smith

Whitney W. Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions utilizing quinazolinones
    Patent number: 8658656
    Abstract: Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
    Type: Grant
    Filed: September 12, 2012
    Date of Patent: February 25, 2014
    Assignee: Cytokinetics, Inc.
    Inventors: Jeffrey T. Finer, Gustav S Bergnes, Whitney W. Smith, John C. Chabala, Bainian Feng
  • Methods and compositions utilizing quinazolinones
    Patent number: 8470838
    Abstract: Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
    Type: Grant
    Filed: August 25, 2009
    Date of Patent: June 25, 2013
    Assignee: Cytokinetics, Incorporated
    Inventors: Jeffrey T. Finer, Gustave Bergnes, Whitney W. Smith, John C. Chabala, Bainian Feng
  • METHODS AND COMPOSITIONS UTILIZING QUINAZOLINONES
    Publication number: 20130053408
    Abstract: Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
    Type: Application
    Filed: September 12, 2012
    Publication date: February 28, 2013
    Inventors: Jeffrey T. Finer, Gustave S. Bergnes, Whitney W. Smith, John C. Chabala, Bainian Feng
  • Methods and compostions utilizing quinazolinones
    Patent number: 8008311
    Abstract: Quinazolinones of formulae (a, b, c and d) are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
    Type: Grant
    Filed: February 11, 2010
    Date of Patent: August 30, 2011
    Assignee: Cytokinetics, Inc.
    Inventors: Jeffrey T. Finer, Gustave Bergnes, Bainian Feng, Whitney W. Smith, John C. Chabala
  • METHODS AND COMPOSTIONS UTILIZIING QUINAZOLINONES
    Publication number: 20100210670
    Abstract: Quinazolinones of formulae (a, b, c and d) are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
    Type: Application
    Filed: February 11, 2010
    Publication date: August 19, 2010
    Inventors: Jeffrey T. Finer, Gustave Bergnes, Bainian Feng, Whitney W. Smith, John C. Chabala
  • Methods and compositions utilizing quinazolinones
    Patent number: 7763628
    Abstract: Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
    Type: Grant
    Filed: April 17, 2007
    Date of Patent: July 27, 2010
    Assignee: Cytokinetics, Inc.
    Inventors: Jeffrey T. Finer, Gustav E Bergnes, Whitney W. Smith, John C. Chabala, Bainian Feng
  • Methods and Compositions Utilizing Quinazolinones
    Publication number: 20100063073
    Abstract: Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
    Type: Application
    Filed: August 25, 2009
    Publication date: March 11, 2010
    Inventors: Jeffrey T. Finer, Gustave Bergnes, Whitney W. Smith, John C. Chabala, Bainian Feng
  • Methods and compositions utilizing quinazolinones
    Patent number: 7589098
    Abstract: Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
    Type: Grant
    Filed: March 21, 2005
    Date of Patent: September 15, 2009
    Assignee: Cytokinetics, Inc.
    Inventors: Jeffrey T. Finer, Gustave Bergnes, Whitney W. Smith, John C. Chabala, Bainian Feng
  • Methods and compositions utilizing quinazolinones
    Publication number: 20080182864
    Abstract: Quinazolinones of formulae (a, b, c and d) are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
    Type: Application
    Filed: June 28, 2007
    Publication date: July 31, 2008
    Inventors: Jeffrey T. Finer, Gustave Bergnes, Bainian Feng, Whitney W. Smith, John C. Chabala
  • Methods and compositions utilizing quinazolinones
    Patent number: 7294634
    Abstract: Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed.
    Type: Grant
    Filed: July 20, 2004
    Date of Patent: November 13, 2007
    Assignee: Cytokinetics, Inc.
    Inventors: Jeffrey T. Finer, Gustave Bergnes, Whitney W. Smith, John C. Chabala, Bainian Feng
  • Methods and compositions utilizing quinazolinones
    Patent number: 7230000
    Abstract: Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: June 12, 2007
    Assignee: Cytokinetics, Incorporated
    Inventors: Jeffrey T. Finer, Gustave Bergnes, Whitney W. Smith, John C. Chabala, Bainian Feng
  • Compounds, compositions, and methods
    Patent number: 7211580
    Abstract: Compounds, compositions and methods useful for treating cellular proliferative diseases and disorders, for example, by modulating the activity of KSP, are disclosed.
    Type: Grant
    Filed: July 23, 2003
    Date of Patent: May 1, 2007
    Assignee: Cytokinetics, Incorporated
    Inventors: Gustave Bergnes, Whitney W. Smith, Bing Yao, David J. Morgans, Jr., Andrew MacDonald
  • Methods and compositions utilizing quinazolinones
    Patent number: 7105668
    Abstract: Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: September 12, 2006
    Assignee: Cytokinetics, Inc.
    Inventors: Gustave Bergnes, Whitney W. Smith, John C. Chabala
  • Methods and compositions utilizing quinazolinones
    Publication number: 20040254203
    Abstract: Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
    Type: Application
    Filed: July 20, 2004
    Publication date: December 16, 2004
    Applicant: Cytokinetics, Inc.
    Inventors: Jeffrey T. Finer, Gustave Bergnes, Whitney W. Smith, John C. Chabala, Bainian Feng
  • Methods and compositions utilizing quinazolinones
    Patent number: 6831085
    Abstract: Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: December 14, 2004
    Assignee: Cytokinetics, Inc.
    Inventors: Gustave Bergnes, Whitney W. Smith, John C. Chabala
  • Process for the racemization of chiral quinazolinones
    Publication number: 20040192913
    Abstract: Racemates are obtained from one of the enantiomers, or an enantiomerically enriched mixture, of an optically active quinazolinone derivative by reaction of the compound with an alkali alkoxide of a primary alcohol and isolation of the racemate.
    Type: Application
    Filed: February 6, 2004
    Publication date: September 30, 2004
    Applicant: CYTOKINETICS, INC.
    Inventors: Gustave Bergnes, Bing Yao, David Morgans, Whitney W. Smith
  • Compounds, compositions, and methods
    Publication number: 20040142949
    Abstract: Compounds, compositions and methods useful for treating cellular proliferative diseases and disorders, for example, by modulating the activity of KSP, are disclosed.
    Type: Application
    Filed: July 23, 2003
    Publication date: July 22, 2004
    Inventors: Gustave Bergnes, Whitney W. Smith, Bing Yao, David J. Morgans, Andrew McDonald
  • Process for the racemization of chiral quinazolinones
    Patent number: 6753428
    Abstract: Racemates are obtained from one of the enantiomers, or an enantiomerically enriched mixture, of an optically active quinazolinone derivative by reaction of the compound with an alkali alkoxide of a primary alcohol and isolation of the racemate.
    Type: Grant
    Filed: November 20, 2002
    Date of Patent: June 22, 2004
    Assignee: Cytokinetics, Inc.
    Inventors: Gustave Bergnes, Bing Yao, David Morgans, Jr., Whitney W. Smith
  • Methods and compositions utilizing quinazolinones
    Publication number: 20040023996
    Abstract: Quinazolinones of formulae (a, b, c and d) are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
    Type: Application
    Filed: August 15, 2003
    Publication date: February 5, 2004
    Inventors: Jeffrey T. Finer, Gustave Bergnes, Bainian Feng, Whitney W. Smith, John C. Chabala, David J. Morgans Jr
  • Methods and compositions utilizing quinazolinones
    Patent number: 6630479
    Abstract: Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: October 7, 2003
    Assignee: Cytokinetics, Inc.
    Inventors: Jeffrey T. Finer, Gustave Bergnes, Whitney W. Smith, John C. Chabala, Bainian Feng